Evidence map›Paper›PMID 36153607›Full record

ArticleAlzheimer's research & therapy2022

Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease.

Anna Rubinski, Nicolai Franzmeier, Anna Dewenter, Ying Luan, Ruben Smith, Olof Strandberg, Rik Ossenkoppele, Martin Dichgans, Oskar Hansson, Michael Ewers and 1 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. When myelin breaks, tau aggregates - a new perspective on Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  3. Modular brain networks shape amyloid-driven tau spread and cognitive decline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. A lifespan staging model of basal forebrain cholinergic vulnerability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Exploiting glial cell functions for neurodegeneration therapy.Neuroprotection (Chichester, England) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Multimodal spatial gradients to explain regional susceptibility to fibrillar tau in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Article
  17. Astrocyte and oligodendrocyte pathology in Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Anna RubinskiInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Nicolai FranzmeierInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Anna DewenterInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Ying LuanInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Ruben SmithDepartment of Neurology, Skåne University Hospital, Lund, Sweden.
Olof StrandbergClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Rik OssenkoppeleClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Martin DichgansInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Oskar HanssonClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Michael EwersInstitute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany. Michael.Ewers@med.uni-muenchen.de.
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Lund University · SEGerman Center for Neurodegenerative Diseases · DELMU Klinikum · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Alzheimer's disease (AD), fibrillar tau initially occurs locally and progresses preferentially between closely connected regions. However, the underlying sources of regional vulnerability to tau pathology remain unclear. Previous brain-autopsy findings suggest that the myelin levels-which differ substantially between white matter tracts in the brain-are a key modulating factor of region-specific susceptibility to tau deposition. Here, we investigated whether myelination differences between fiber tracts of the human connectome are predictive of the interregional spreading of tau pathology in AD.

methodsWe included two independently recruited samples consisting of amyloid-PET-positive asymptomatic and symptomatic elderly individuals, in whom tau-PET was obtained at baseline (ADNI: n = 275; BioFINDER-1: n = 102) and longitudinally in a subset (ADNI: n = 123, mean FU = 1.53 [0.69-3.95] years; BioFINDER-1: n = 39, mean FU = 1.87 [1.21-2.78] years). We constructed MRI templates of the myelin water fraction (MWF) in 200 gray matter ROIs and connecting fiber tracts obtained from adult cognitively normal participants. Using the same 200 ROI brain-parcellation atlas, we obtained tau-PET ROI values from each individual in ADNI and BioFINDER-1. In a spatial regression analysis, we first tested the association between cortical myelin and group-average tau-PET signal in the amyloid-positive and control groups. Secondly, employing a previously established approach of modeling tau-PET spreading based on functional connectivity between ROIs, we estimated in a linear regression analysis, whether the level of fiber-tract myelin modulates the association between functional connectivity and longitudinal tau-PET spreading (i.e., covariance) between ROIs.

resultsWe found that higher myelinated cortical regions show lower tau-PET uptake (ADNI: rho =  - 0.267, p < 0.001; BioFINDER-1: rho =  - 0.175, p = 0.013). Fiber-tract myelin levels modulated the association between functional connectivity and tau-PET spreading, such that at higher levels of fiber-tract myelin, the association between stronger connectivity and higher covariance of tau-PET between the connected ROIs was attenuated (interaction fiber-tract myelin × functional connectivity: ADNI: β =  - 0.185, p < 0.001; BioFINDER-1: β =  - 0.166, p < 0.001).

conclusionHigher levels of myelin are associated with lower susceptibility of the connected regions to accumulate fibrillar tau. These results enhance our understanding of brain substrates that explain regional variation in tau accumulation and encourage future studies to investigate potential underlying mechanisms.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAdultAgedAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsBrainHumansMagnetic Resonance ImagingMyelin SheathPositron-Emission Tomographytau ProteinsAmyloidAmyloid beta-PeptidesAmyloidogenic Proteinstau ProteinsAlzheimer’s diseaseAmyloid-PETMyelinMyelin water fractionResistanceTau-PETTau spreading

Identifiers

PMID36153607
PMCPMC9508747
OpenAlexW4296977733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.